Miraculins - 500 % Deal 2014 !

Diabetes Markt  in China ist gewaltig - Miraculins hat aktuell einen Börsenwert von nur 3,3 Mio € !!!! Wird der Deal unterzeichnet explodiert die Aktie auf 0,50 $ !!!

Miraculins Aktie [WKN: A0NEJ0 / ISIN: CA60462L1085]

Miraculins still in talks with Cachet over Scout DS

2013-12-31 06:41 ET - News Release

Mr. Christopher Moreau reports

MIRACULINS AND CACHET PHARMACEUTICAL AGREE TO 30-DAY EXTENSION ON LETTER OF INTENT TO CONTINUE NEGOTIATION OF LICENSING RIGHTS FOR SCOUT DS(R) DIABETES TEST IN CHINA

Miraculins Inc.'s non-binding letter of intent the company executed with Cachet Pharmaceutical Co. Ltd. on Sept. 30, 2013, to provide a non-exclusive 90-day negotiation period for Cachet to acquire an exclusive licence to commercialize the company's Scout DS non-invasive diabetes screening test in China, has been extended by mutual agreement of the parties for an additional 30-day period ending Jan. 30, 2014.

"The parties continue to engage in meaningful discussions regarding the establishment and execution of a definitive licensing agreement," said Christopher J. Moreau, president and chief executive officer of Miraculins. "Miraculins and Cachet concur that additional time is required in order to further pursue discussions."

Any licensing agreement advanced would be subject to satisfactory due diligence, definitive documentation and board approval by both parties respectively.

We seek Safe Harbor.

© 2014 Canjex Publishing Ltd. All rights reserved.

kurzfristig 0,15 $ - mittelfristig 0,50 $ !
Diese Pharmaaktie wird in Kürze deutlich durchstarten !

Very good news
The Miraculins stock will achieve a sensational performance in 2014. The stock guaranteed by the current share price significant gains.

The stock is now being discovered by the financial press as clear winners share for 2014.

__________________________________________________

Miraculins - Recommendation in the financial press

Brandon Sun - ONLINE EDITION
By: Martin Cash
Friday, Jan. 3, 2014 at 7:52 AM

The biggest to the smallest: 2014 will prove to be a big year for several companies. Everyone knows James Richardson and Sons is one of the largest private companies in the country but it has not got as much attention as it should have after quietly growing much larger both in the agricultural sector and in the financial services. Look for even more muscle flexing in 2014. At other end of the spectrum, there are a number of smaller bio-tech and info-tech companies on the verge of bigger and better things such as Miraculins, Kane Biotech, Cubresa, Marsala Biotech, Wolf Trax, Invenia, Reclaim IO and Joist.